Loading…
Hosted by Unknown Host · 🇺🇸 US · EN · 87 episodes
Established thought leaders with verified media credentials.
CReATe Connect podcasts are short recorded interviews on topics we hope will be of interest to patients with ALS and other motor neuron diseases.
Unknown Host hosts CReATe Podcast, a health show with 87 episodes published.
Alpha-lipoic acid (ALA) is a naturally occurring fatty acid. It has several plausible mechanisms for slowing ALS progression. Preclinical studies showed ALA slowed motor function decline. Some patients reported improveme
Paul Lingor, MD, is Professor for Neurology, Group Leader and Head of the Outpatient Clinics for Motoneuron Disorders and Co-head of the Outpatient Clinics for Movement Disorders and at the Department of Neurology of the
Portable Neuromodulation Stimulator (PoNS) is a type of electrical stimulation that can theoretically increase rewiring in the brain (neuroplasticity). Small trials suggest that it can improve walking in MS but thus far
ISRIB stands for “integrated stress response inhibitor). As we discuss here, it is an oral medication that inhibits an intracellular pathway called the integrative stress response pathway. It is not FDA approved for any
Dr. Michael Benatar is a Professor of Neurology and Chief of the Neuromuscular Division and Executive Director of the ALS Center at the University of Miami. Here he discusses the recent publication “Proposed Research Cri
Here we have a podcast produced by artificial intelligence discussing the recent publication “Design considerations for C9orf72 disease prevention trials”.
The Wahls Protocol is a diet that may reduce inflammation, oxidative stress, and mitochondrial dysfunction. Although these are plausible mechanisms for slowing ALS progression, we discuss the fact that there are no actua
Psilocybin is a psychedelic chemical derived from mushrooms. It is under study for mood problems in people with ALS. Here we review its plausible mechanisms for slowing ALS progression. But there are no data from preclin
Here we review ashwagandha a nutritional supplement that has plausible mechanisms for slowing ALS, promising pre-clinical evidence, and a reasonable safety profile. There is one person with ALS who experienced a reversal
Dr. Johnathan Cooper-Knock is a neurologist and clinical lecturer at the University of Sheffield. His research focuses on genetic causes of ALS. Here he discusses his recent publication “Extreme exercise in males is link
Here we review Zinc supplements as a treatment for ALS. These are inexpensive, reasonably safe at certain doses, and are easy to acquire. They have plausible mechanisms by which they could slow ALS progression. However,
Dr. Terry Heiman-Patterson is a neurologist and professor at Temple University and the director of the Center for Neurodegenerative Disorders and the MDA/ALS Center of Hope. Dr. Michael Benatar is a Professor of Neurolog
Dr. Ruben van Eijk is an associate professor in the Department of Neurology at the University Medical Center Utrecht in the Netherlands as well as a statistical consultant and medical statistician for the clinical trial
Dr. Michael Benatar is a Professor of Neurology and Chief of the Neuromuscular Division and Executive Director of the ALS Center at the University of Miami. Here he discusses the recent publication “Prognostic clinical a
Dr. Jesse Crayle is a clinical neuromuscular fellow in the Department of Neurology at Washington University in St. Louis and Dr. Evadnie Rampersaud is a Principal Bioinformatics Research Scientist at St. Jude Children’s
Nuedexta is a combination of dextromethorphan and quinidine, and is FDA approved for treating “pseudobulbar affect” (a symptom complex where patients lose control of their laughing and crying). Here we summarize recent t
Lions Mane is a mushroom that has neuroprotective, neurotrophic, antioxidant, and anti-inflammatory properties. Here we review what is known about its use in ALS models as well as patients living with the disease.
Insulin is a hormone most commonly used to lower blood sugar in people with diabetes. Here we talk about some theoretical ways it might help help people with ALS, as well as the lack of convincing case reports or trials
Caffeine is a chemical most of us ingest every day. In addition to its stimulant properties, there are some theoretical ways it could help slow ALS progression. Here we discuss the contradictory pre-clinical models and t
Michael Benatar is a Professor of Neurology and Chief of the Neuromuscular Division and Executive Director of the ALS Center at the University of Miami. Here he discusses the recent publication “The Miami Framework for A
Dr. Michael Benatar
University of Miami
3 appearances on this show
Dr. Johnathan Cooper-Knock
University of Sheffield
1 appearance on this show
Terry Heiman-Patterson
Temple University
1 appearance on this show
Michael Benatar
University of Miami
3 appearances on this show
Ruben van Eijk
University Medical Center Utrecht
1 appearance on this show
Evadnie Rampersaud
St. Jude Children’s Research Hospital
1 appearance on this show
Jesse Crayle
Washington University in St. Louis
1 appearance on this show
Dr. Caroline McHutchison
University of Edinburgh
1 appearance on this show
Dr. Chad Heatwole
University of Rochester Medical Center
1 appearance on this show
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
CReATe Podcast has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their health audience.
CReATe Podcast is hosted by Unknown Host. The show is categorised under Health (fitness) and has published 87 episodes.
CReATe Podcast has published 87 episodes.
CReATe Podcast regularly covers Health, Fitness. It sits in the Health category, with a fitness focus.
CReATe Podcast is accessible for guests with genuine health expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
CReATe Podcast hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of CReATe Podcast average 22 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates CReATe Podcast's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched today.